Mannkind (MNKD) Convertible Debt (2010 - 2024)
Mannkind's (MNKD) quarterly Convertible Debt came in at $36.1 million in Q4 2024, down 84.11% year-on-year from $226.9 million in Q1 2024, and down 84.18% on a QoQ basis from $227.9 million in Q3 2024.
Mannkind (MNKD) Convertible Debt (2010 - 2024) Analysis & Trends
Mannkind (MNKD) has 15 years of Convertible Debt data on file, last reported at $36.1 million in Q4 2024.
- On a quarterly basis, Convertible Debt fell 84.11% year-over-year to $36.1 million in Q4 2024; TTM through Dec 2024 was $36.1 million, a 84.11% decrease from a year earlier, with the FY2024 full-year figure at $36.1 million, down 84.11% from the prior year.
- Convertible Debt for Q4 2024 stood at $36.1 million, down from $227.9 million in the prior quarter.
- Over the last five years, Convertible Debt for MNKD reached as high as $227.9 million in Q3 2024 and fell as low as $5.0 million in Q1 2020.
- Historically, Convertible Debt has averaged $117.1 million across 5 years, with a median of $129.8 million in 2021.
- Across the five-year window, Convertible Debt plunged 97.76% in 2022 and jumped 4429.74% in 2023, its largest moves.
- Year by year, Convertible Debt stood at $5.0 million in 2020, then changed by 0.0% to $5.0 million in 2021, then surged by 4407.94% to $225.4 million in 2022, then advanced by 0.65% to $226.9 million in 2023, then plunged by 84.11% to $36.1 million in 2024.
- Per Business Quant data, the three most recent Convertible Debt figures were $36.1 million in Q4 2024, $227.9 million in Q3 2024, and $227.6 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 36.05 Mn |
| Sep 30, 2024 | 227.94 Mn |
| Jun 30, 2024 | 227.58 Mn |
| Mar 31, 2024 | 227.21 Mn |
| Dec 31, 2023 | 226.85 Mn |
| Sep 30, 2023 | 226.49 Mn |
| Jun 30, 2023 | 226.12 Mn |
| Mar 31, 2023 | 225.76 Mn |
| Dec 31, 2022 | 225.40 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 224.31 Mn |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 223.58 Mn |
| Jun 30, 2021 | 5.00 Mn |
| Mar 31, 2021 | 5.00 Mn |
| Dec 31, 2020 | 5.00 Mn |
| Sep 30, 2020 | 5.00 Mn |
| Jun 30, 2020 | 5.00 Mn |
| Mar 31, 2020 | 5.00 Mn |